Agilent Technologies Prices $400 Million of Senior Notes
News Sep 11, 2012
Agilent Technologies Inc. announced the pricing of a series of its senior notes in an aggregate principal amount of $400 million, in an underwritten, registered public offering. The notes will mature in October 2022 and will bear interest at an annual rate of 3.20 percent. The offering is expected to close on September 13, 2012, subject to customary closing conditions.
Barclays Capital Inc., J.P. Morgan Securities LLC and Merrill Lynch, Pierce, Fenner & Smith Incorporated are acting as joint book-running managers.
Copies of the prospectus supplement and the accompanying prospectus relating to the offering can be obtained from:
Barclays Capital Inc.
745 Seventh Avenue
New York, NY 10019
J.P. Morgan Securities LLC
383 Madison Avenue
New York, NY 10179
Merrill Lynch, Pierce, Fenner & Smith Inc.
One Bryant Park
New York, NY 10036
Electronic copies of the prospectus supplement and accompanying prospectus are also available on the Securities and Exchange Commission website at www.sec.gov.
This press release does not constitute an offer to sell or the solicitation of an offer to buy any of the securities nor shall there be any sale of these securities in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state.
Changes Identified in Body Cells During Type2 Diabetes OnsetNews
Researchers have found fresh evidence to explain the processes that occur in the body’s cells leading to the onset of type2 diabetes. Utilising metabolomics, results showed that amino acids play a contributory role in the onset of type2 diabetes in some younger and older patients, as the metabolism of specific amino acids is adversely affected.
Blood Sample Detection Method for Multiple Sclerosis DiscoveredNews
A method for quickly detecting signs of multiple sclerosis has been developed by a University of Huddersfield research team. The process will avoid the invasive, painful process of collecting fluid from the brain and spineREAD MORE
Honey Bee Gut Metabolome Reveals How They Cope With a Pollen Rich DietNews
The honey bee gut is colonized by specialized bacteria that help digest components of the floral pollen diet and produce molecules that likely promote bee health. Researchers studied the metabolome from the bee gut and have uncovered which bacterial species perform which specific digestive functions.